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Abstract
Background: Quorum sensing is a term describing a bacterial communication system mediated
by the production and recognition of small signaling molecules. The LuxS enzyme, catalyzing the
synthesis of AI-2, is conserved in a wide diversity of bacteria. AI-2 has therefore been suggested as
an interspecies quorum sensing signal. To investigate the role of endogenous AI-2 in protein
expression of the Gram-negative pathogen Salmonella enterica serovar Typhimurium (S.
Typhimurium), we performed a 2D-DIGE proteomics experiment comparing total protein extract
of wildtype S. Typhimurium with that of a luxS mutant, unable to produce AI-2.
Results: Differential proteome analysis of wildtype S. Typhimurium versus a luxS mutant revealed
relatively few changes beyond the known effect on phase 2 flagellin. However, two highly
differentially expressed protein spots with similar molecular weight but differing isoelectric point,
were identified as LuxS whereas the S. Typhimurium genome contains only one luxS gene. This
observation was further explored and we show that the S. Typhimurium LuxS protein can undergo
posttranslational modification at a catalytic cysteine residue. Additionally, by constructing LuxS-βla
and LuxS-PhoA fusion proteins, we demonstrate that S. Typhimurium LuxS can substitute the
cognate signal peptide sequences of β-lactamase and alkaline phosphatase for translocation across
the cytoplasmic membrane in S. Typhimurium. This was further confirmed by fractionation of S.
Typhimurium protein extracts, followed by Western blot analysis.
Conclusion: 2D-DIGE analysis of a luxS mutant vs. wildtype Salmonella Typhimurium did not reveal
new insights into the role of AI-2/LuxS in Salmonella as only a small amount of proteins were
differentially expressed. However, subsequent in depth analysis of the LuxS protein itself revealed
two interesting features: posttranslational modification and potential translocation across the
cytoplasmic membrane. As the S. Typhimurium LuxS protein does not contain obvious signal
motifs, it is speculated that LuxS is a new member of so called moonlighting proteins. These
observations might have consequences in future studies on AI-2 quorum signaling in S.
Typhimurium.
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Background
Several bacteria utilize a cell-cell communication system
called quorum sensing to coordinate diverse behaviors in
response to population density [1]. This quorum sensing
process is based on the generation of small signaling mol-
ecules by means of specific synthases. These signaling
molecules accumulate into the extracellular environment
and when a certain threshold concentration is reached,
the bacteria detect and respond to this signal by altering
their gene expression. Although several quorum sensing
systems are known, the synthase highly conserved in
many both Gram-negative and Gram-positive bacterial
species is the quorum sensing synthase LuxS [2,3]. This
enzyme catalyzes the conversion of S-ribosylhomo-
cysteine to 4,5-dihydroxy-2,3-pentanedione (DPD) and
homocysteine [4]. The unstable DPD spontaneously
cyclizes into a family of interconverting molecules, collec-
tively referred to as autoinducer-2 (AI-2) [5].
One of the first species reported to produce and respond
to AI-2 resulting in expression of its luminescence genes is
the marine pathogen Vibrio harveyi [6]. This bacterial spe-
cies has been used as a bioreporter system in subsequent
studies as it is able to detect and respond to AI-2 mole-
cules produced by other bacteria that contain a functional
LuxS protein [7,8]. AI-2 has therefore been postulated to
be a universal language for interspecies communication.
Based on the analysis of luxS mutants, a variety of pheno-
types such as motility, cell division, virulence, biofilm for-
mation, and bioluminescence have been attributed to AI-
2 mediated quorum sensing [9,10]. However, the reaction
catalyzed by LuxS is part of the activated methyl cycle, a
metabolic pathway for the recycling of the major cellular
methyl donor S-adenosylmethionine. As such, AI-2 can
also be seen as a merely metabolic side product and the
function of AI-2 might differ with the bacterial species
under investigation [11]. In this respect it is interesting to
note that in some cases, luxS phenotypes cannot be com-
plemented by addition of exogenous AI-2 [12-16].
The only operon identified to date being directly regulated
by AI-2 in S. Typhimurium, is the lsr operon encoding an
ABC-type transporter for the uptake of AI-2 and some
enzymes involved in AI-2 catabolism [17]. To date, the
purpose of this uptake of AI-2 remains unclear. LuxS has
also been linked to virulence, biofilm formation and flag-
ellar phase variation [12,13,18,19]. For biofilm formation
and flagellar phase variation, the phenotype could not be
complemented by addition of synthetic DPD and conse-
quently seem independent of AI-2 [12,13]. In order to get
more insight in the role of AI-2 in S. Typhimurium, we
performed a two-dimensional difference-in-gel electro-
phoresis experiment (2D-DIGE) comparing a luxS mutant
with wildtype S. Typhimurium at the proteome level. Sur-
prisingly, among the differential proteins identified, two
distinct protein spots corresponded to LuxS. This observa-
tion was further explored and we show that in S. Typh-
imurium, LuxS can be posttranslationally modified on a
cysteine residue that is crucial for enzymatic activity. Addi-
tionally, for the first time, evidence is presented that LuxS
contains functional sequence information allowing trans-
location across the cytoplasmic membrane.
Results
2D-DIGE analysis
Total protein samples were taken from a wildtype S. Typh-
imurium strain and a luxS mutant. The mutant proteome
was compared to that of the wildtype strain using 2D-
DIGE. With this technique, protein samples are labelled
prior to separation with up to three different fluorescent
Cy dyes, allowing to load three different samples and
incorporate an identical internal standard sample on each
gel. Including such an internal standard, which is a pool
of all experimental samples, minimizes the result varia-
tion related to the system, common in 2D-gelelectro-
phoresis (2DE) [20]. Details of the experimental setup can
be found in the Methods section. Statistical analysis
revealed 6 spots showing differential expression (p-value
< 0.01 and fold increase/decrease > 1.5) between wildtype
and the luxS  mutant (see Figure 1). Differentially
expressed protein spots were picked from preparative gels
for identification with MALDI-TOF mass spectrometry
(see Table 1). Due to low abundance, some spots could
not be identified unambiguously, revealing a drawback of
working with gel-based proteomics. Phase 2 flagellin was
downregulated in the luxS mutant, corresponding to what
was previously reported by Karavolos et al. [12]. An
intriguing observation was the fact that two distinct pro-
tein spots, absent in the luxS  mutant as compared to
wildtype, were identified by mass spectrometry as being
LuxS. This result led us to investigate the LuxS protein
itself in more detail.
LuxS modification
Based on the relative position of the two LuxS spots on the
gels and the theoretical pI of LuxS as calculated with Scan-
Site pI/MW, the most basic (right) spot (Figure 2A) corre-
sponds to the native LuxS form while the other spot
corresponds to LuxS with an additional negative charge.
Efforts to identify the nature of this modification by tan-
dem mass spectrometry were unsuccessful. Phosphoryla-
tion is a common posttranslational modification that
induces a protein shift to the acidic side of 2D gels due to
the negative charge of the phosphate group. Moreover,
LuxS proteins from several Gram-negative bacteria con-
tain a semi-conserved tyrosine phosphorylation site motif
[21]. This led us to investigate whether the modification
of LuxS in S. Typhimurium corresponds to a tyrosine
phosphorylation. First, we attempted to detect a phospho-
rylated form of LuxS using the phosphospecific ProQ-Dia-BMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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mond stain (Invitrogen) on a 2D gel. However, no LuxS
spot could be detected in this way (data not shown). Sec-
ondly, Western blotting using anti-phosphotyrosine anti-
bodies was performed on an immunoprecipitated LuxS
protein fraction. This immunoprecipitation step increases
the LuxS concentration to facilitate detection of a putative
phosphorylated form. Yet, LuxS could not be detected by
these antibodies, making a tyrosine phosphorylation
unlikely (data not shown). Subsequently, luxS constructs
were made containing specific point mutations in each of
the three LuxS tyrosine (Y) residues. These amino acids
were changed into either a phenylalanine (F) residue that
cannot become phosphorylated or an aspartate (D) resi-
due to mimic a modification resulting in an additional
negative charge. All constructs were functionally active,
i.e. AI-2 was still produced by these modified proteins
(data not shown). Total protein lysates of S. Typhimu-
rium luxS mutant strains containing one of these point
Image of the master gel used in the 2D-DIGE analysis comparing the proteome of wildtype S. Typhimurium with that of a luxS  mutant Figure 1
Image of the master gel used in the 2D-DIGE analysis comparing the proteome of wildtype S. Typhimurium 
with that of a luxS mutant. Spots with white spot boundaries were differentially expressed. The numbers indicated, corre-
spond to the spot numbers in Table 1.BMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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mutated LuxS constructs, were analyzed with 2D gel elec-
trophoresis (2DE). As shown in Figure 2D-F, all strains
with Y to F mutations still possess two LuxS spots. This
rules out any of the tyrosine residues as target sites for
modification. Furthermore, the pI shift seen in the Y to D
mutation strains (Figure 2G-I) confirms the charge differ-
ence on the modified LuxS form. This result also illus-
trates that the interpretation of proteomic results has to be
done with great care. Posttranslational modifications all
correspond to a specific shift in pI and/or molecular
weight. In this respect, we suggest that the postulated
phosphorylation of LuxS in Bifidobacterium longum pro-
posed by Yuan et al. should be re-investigated [22].
For Bacillus subtilis LuxS, oxidation of C84 has previously
been reported with purified LuxS protein in studies to
reveal the reaction mechanism of the synthase [23-25].
This oxidation is irreversible and adds one negative charge
to the protein [23], which makes it a good candidate for
the LuxS modification we detected in the S. Typhimurium
proteome. Analogous to the tyrosine mutant constructs,
we made a point mutation of the corresponding cysteine
residue in S. Typhimurium to an alanine residue (C83A)
which can no longer be oxidized and subsequently ana-
lyzed this strain by 2DE. As shown in Figure 2J the C83A
luxS strain lacks the acid shifted LuxS spot confirming C83
as the target for posttranslational modification. As this
Table 1: Differentially expressed spots in the 2D-DIGE analysis
Spot nr.a Name Description Protein IDb Av. Ratioc p-valued
luxS mutant vs. wildtype
1L u x S S-ribosylhomocysteine lyase Q9L4T0 -13.50 9.80E-04
2L u x S S-ribosylhomocysteine lyase Q9L4T0 -9.77 1.70E-03
3 n.i. n.i n.i. -3.94 7.00E-03
4 FljB Phase 2 flagellin P52616 -2.11 5.00E-04
5 FljB Phase 2 flagellin P52616 -1.75 8.00E-04
6 n.i. n.i. n.i. -1.72 1.40E-03
a Corresponding spot number on the gel image in Figure 1
b Protein identification number
c Average fold increase (positive ratio) or decrease (negative ratio) in expression of a protein in the mutant compared to the wildtype
d P-value of the t-test analysis comparing the mutants to the wildtype
n.i. indicates not identified
2DE analysis of Salmonella Typhimurium luxS mutants Figure 2
2DE analysis of Salmonella Typhimurium luxS mutants. (A) Total gel image of wildtype S. Typhimurium proteins. The 
two LuxS forms are indicated with an arrow. Based on pI calculations, the right spot corresponds to native LuxS and the left 
spot carries a posttranslational modification. (B-J) Close-up view of the area of the LuxS spots in a luxS mutant carrying differ-
ent LuxS complementation constructs. (B) negative control - empty vector; (C) wildtype LuxS; (D) LuxS-Y88F; (E) LuxS-Y126F; 
(F) LuxS-Y131F; (G) LuxS-Y88D; (H) LuxS-Y126D; (I) LuxS-Y131D; (J) LuxS-C83A. Remark that in theory, on the gels from 
which panels G-I are taken, an additional modified LuxS spot is expected, accumulating the Y to D mutation and the cysteine 
modification.BMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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cysteine residue is required for LuxS catalytic activity [26],
the LuxSC83A mutant strain failed to produce AI-2 as
revealed by the use of the AI-2 bioassay [27] (data not
shown).
LuxS localization
Apart from posttranslational modification, we also exam-
ined the subcellular localization of LuxS, a feature that has
not been investigated previously. It has been assumed that
the LuxS protein localizes in the cytosol. A chromosomal
translational fusion was made between LuxS and the peri-
plasmic reporter protein β-lactamase. Expression of a β-
lactamase results in resistance against β-lactam antibiotics
such as ampicillin. However, to confer this resistance in
Gram-negative bacteria, β-lactamase has to be exported
outside the cytoplasm since formation of disulfide bridges
is a prerequisite for enzyme activity [28,29]. An in frame
gene construct encoding LuxS followed by a truncated β-
lactamase lacking its native signal peptide was inserted
into the chromosome of S. Typhimurium. The strain with
the fusion construct was subsequently analyzed for
growth at 37°C in liquid LB medium containing variable
concentrations of ampicillin. As expected, a wildtype
strain is highly sensitive to ampicillin. The luxSβla fusion
strain, however, showed a clear increase in ampicillin
resistance (Figure 3A). As the two strains differ also in syn-
thesis of AI-2 because the LuxS-βla fusion protein is not
expected to have AI-2 synthase activity, synthetic DPD was
also added to the growth medium. However, this did not
alter the observed difference in ampicillin resistance (data
not shown). Increased ampicillin resistance and thus an
active β-lactamase implies that the LuxS-βla fusion pro-
tein is translocated across the cytoplasmic membrane.
To confirm this interesting observation, a second fusion
was made between LuxS and another periplasmic reporter
protein, the alkaline phosphatase PhoA. Similar to β-
lactamase, this enzyme requires disulfide bridge forma-
tion for correct folding and activity and has proven to be
a useful tool for topology analysis [30]. An in frame gene
construct encoding LuxS followed by a truncated PhoA
lacking its native signal peptide was made. Additionally,
two constructs encoding PhoA either with (positive con-
trol, PhoA+SP) or without (negative control, PhoA-SP)
cognate signal peptide, both under the control of a consti-
tutive promoter, were included in this experiment. To
minimize background activity, a Salmonella ΔphoN strain
lacking its own acid phosphatase gene was constructed
and used for all further analyses. Results from the PhoA
activity analysis are shown in Figure 3B-C. The strain with
the luxSphoA fusion displays alkaline phosphatase activity
similar to the positive control strain, both when grown on
agar plates containing the chromogenic substrate 5-
bromo-4-chloro-3-indolyl phosphate (BCIP) (Figure 3B)
and in an enzymatic assay using p-nitrophenyl phosphate
(pNPP) as a substrate (Figure 3C). Conversely, the nega-
tive control strain does not express active alkaline phos-
phatase, although the PhoA protein could be detected on
a Western blot using anti-PhoA antibodies (Figure 3D),
indicating that PhoA is present but remains in the cyto-
plasm in this negative control. Further direct proof for the
subcellular location of the LuxS-PhoA fusion protein was
obtained by subcellular fractionation of S. Typhimurium
proteins into periplasmic, membrane and cytoplasmic
fractions followed by Western blotting and detection with
anti-PhoA antibodies. It can be seen that the LuxS-PhoA
fusion protein is present in all fractions, similarly to the
PhoA protein with its cognate signal peptide (PhoA+SP).
The PhoA protein without its cognate signal peptide
(PhoA-SP) is absent in the periplasmic fraction, as
expected (Figure 3D). Detection of known control pro-
teins (MBP for the periplasm and OmpA for the mem-
brane fraction) shows that the fractionation protocol
worked well, with only minor contaminations.
Finally, subcellular protein fractionation was performed
on a S. Typhimurium strain chromosomally expressing C-
terminal FLAG-tagged LuxS (CMPG5649). As shown in
Figure 3E, the LuxS protein could be detected in all frac-
tions though most abundant in the cytoplasmic fraction.
From the results of these three independent experimental
approaches, it can be concluded that the S. Typhimurium
LuxS protein must contain sequence information for
membrane translocation. As in silico analysis with several
publically available web tools such as PSORTb, LocTree
and SignalP [31-33], did not reveal a typical Sec or Tat sig-
nal peptide for LuxS (data not shown), the mechanism for
its membrane translocation remains unknown.
Discussion
To further investigate the role of AI-2 in the pathogen S.
Typhimurium, we evaluated a luxS mutant in a 2D-DIGE
proteomics approach. Abolishment of AI-2 production
does not cause a drastic change in the proteome of S.
Typhimurium in our experimental set-up. Several factors
should be kept in mind when interpreting this result. First,
a proteome analysis is condition and time point depend-
ent. Second, we used a 2D-DIGE approach to analyze the
proteomic differences. The fluorescent labeling prior to
protein separation permits the incorporation of an inter-
nal standard on each gel making differential proteome
analysis more accurate [34]. In addition, we chose rather
strict cut-off values in our statistical analysis to minimize
false positive results. This specific experimental set-up
could explain differences with a previously reported pro-
teomic study on the effect of AI-2 in Salmonella  [19].
Finally, the 2DE technique is limited both by the pI and
molecular weight range of the first and second dimension,BMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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respectively, and by the low abundance of some protein
spots which hampers their identification.
Nevertheless, 2DE is a powerful high-throughput tech-
nique revealing distinct posttranslational modified pro-
tein forms which are possibly relevant for the
functionality of a protein. We identified two distinct pro-
tein forms of LuxS and this led us to examine this protein
in more detail, more specifically considering posttransla-
tional modification and subcellular localization. In previ-
ous publications it was already mentioned that the exact
function and regulation of the LuxS protein, occurring in
a wide diversity of bacteria, are probably more complex
than anticipated so far [10,11,21,35]. However, apart
from structural and catalytic studies, mainly in B. subtilis,
the LuxS protein itself has not yet been subjected to fur-
ther studies [23-26,36,37].
The two forms of the S. Typhimurium LuxS protein iden-
tified in this study have similar molecular weight, but dif-
Analysis of LuxS localization Figure 3
Analysis of LuxS localization. (A) Growth of S. Typhimurium wildtype and luxSβla with ampicillin. The minimal inhibitory 
concentration (MIC) for sensitivity to ampicillin (μg ml-1) in liquid culture was determined for each strain as described in the 
Methods section. These data are representative for three biological repeats. (B) Strains were grown on LB plates containing 
the chromogenic alkaline phosphatase substrate BCIP. Active alkaline phosphatase converts this substrate into a blue product. 
Negative and positive control strains express PhoA either without or with signal peptide (SP) from a constitutive promoter 
(pCMPG5748 and pCMPG5734); pCMPG5730 expresses a LuxS-PhoA fusion protein. All strains carry a ΔphoN mutation 
(CMPG5726). (C) Strains were grown to mid-exponential phase (OD595 1) and a PhoA activity test was performed. Average 
results of at least 3 biological replicates are shown with standard deviations. (D) Cellular fractionation of LuxS-PhoA fusion and 
control strains. (E) Cellular fractionation of S. Typhimurium expressing chromosomally FLAG-tagged LuxS. Total cells (T), 
grown to OD595 1, were separated into periplasmic (P), cytoplasmic (C) and membrane (M) fractions as described in the Meth-
ods section. The proteins maltose binding protein (MBP), alkaline phosphatase without signal peptide (PhoA-SP) and outer 
membrane protein A (OmpA) were used as periplasmic, cytoplasmic and membrane associated control proteins, respectively. 
All antibodies used are listed in the Methods section. Remarkably, in both panels D an E, the LuxS-PhoA fusion protein and 
FLAG-tagged LuxS protein respectively, seem to differ in molecular weight between the different fractions. This might be 
related to the unknown translocation mechanism.BMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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fering isoelectric points. Point mutation analysis of the
conserved cysteine 83 residue confirmed on the one hand
its importance in the catalytic activity of S. Typhimurium
LuxS and provided on the other hand clear evidence that
the C83A mutation results in only one form of LuxS. From
the latter observation, it can be concluded that the
cysteine 83 residue is the subject of posttranslational
modification of the wildtype LuxS protein in S. Typhimu-
rium extending an observation previously reported for
Bacillus subtilis [23-25]. This result shows that care has to
be taken when interpreting putative posttranslational
modifications. Although S. Typhimurium LuxS contains a
semi-conserved tyrosine phosphorylation motif, our data
do not support that tyrosine phosphorylation is involved.
The previous study of structure and catalytic mechanism
of purified LuxS from the Gram-positive B. subtilis has
demonstrated that a posttranslational modification can
occur at the catalytic site [23-25]. In its active conforma-
tion, LuxS is a homodimer enclosing two identical active
sites at the dimer interface each coordinating a Fe2+ metal
cofactor crucial for enzymatic activity [23]. Pei and cow-
orkers suggest an oxidation mechanism similar to the one
they described for peptide deformylase, another iron con-
taining enzyme with the same coordinating amino acid
residues as LuxS [23,38]. They hypothesize that cysteine
modification is a consequence of the oxidation of the Fe2+
ion coordinated within the active site of LuxS to Fe3+ by
molecular oxygen when substrate is unavailable. Conse-
quently, Fe3+ can no longer be coordinated within LuxS
and leaves the protein.
Although the fate of LuxS lacking its iron cofactor and car-
rying an irreversible cysteine modification is currently
unclear, this oxidation process could be a means of regu-
lating the amount of active LuxS present in the cell accord-
ing to the amount of substrate. AI-2 production has
previously been linked to substrate availability in S. Typh-
imurium as luxS promoter activity has been shown to be
constitutive under standard laboratory conditions [39]. It
will be of interest to further investigate the link between
substrate availability and posttranslational modification
of LuxS.
Another feature of LuxS in S. Typhimurium, namely its
subcellular localization, was studied using complemen-
tary approaches. Our results indicate that LuxS can be
translocated across the plasma membrane. This could
explain the observation of Agudo et al., who identified
LuxS in an overall screening as differentially expressed in
the periplasmic protein fraction of a S. Typhi dsbA mutant
lacking a major disulfide isomerase enzyme [40]. In bac-
teria, two major translocase systems are known to date,
i.e. the Sec and Tat pathway [41]. However, extensive in
silico analysis of the S. Typhimurium LuxS protein did not
reveal a typical Sec or Tat signal peptide for LuxS translo-
cation. Future wet lab experiments involving Salmonella
Sec and Tat mutants are required to elaborate further on
this.
LuxS is not the first enzyme for which an unexpected
localization is observed. An increasing number of both
prokaryotic and eukaryotic proteins are being found in
cellular compartments in addition to the compartment
where their function is best described. They are referred as
promiscuous or moonlighting proteins [42,43]. Having
multiple locations within the cell is a typical feature of
some moonlighting proteins that can contribute to a func-
tional switch. These functions can be enzymatic, but even
structural or regulatory functions are common. Moreover,
many moonlighting proteins are conserved in evolution,
a feature of LuxS [3].
Given the more likely cytoplasmic location of the known
substrate of LuxS, S-ribosyl homocysteine, we propose a
dual, meaning at both sides of the cytoplasmic mem-
brane, localization for LuxS. It will be of interest to further
refine experiments of localization in view of our observa-
tion that a significant band can be observed in the mem-
brane fraction. However, at this stage, we can only
hypothesize what the functional implications of the extra-
cytoplasmic location of LuxS, as revealed in this study,
could be. A kind of shuttling mechanism between cyto-
plasm and periplasm might occur to regulate the amount
of active LuxS. This might be linked to a posttranslational
modification occurring outside the cytoplasmic space
when substrate is unavailable.
Conclusion
A 2D-DIGE experiment comparing a luxS mutant, unable
to synthesize the quorum sensing signal AI-2, with
wildtype S. Typhimurium did not reveal many differences
on the proteome level. Nevertheless, two separate forms
of LuxS with similar molecular weights but differing isoe-
lectric points were identified. Based on this result, we
focused specifically on LuxS. Here, we show that in S.
Typhimurium, LuxS is partly posttranslationally modified
involving a conserved cysteine residue and occurs at both
sides of the cytoplasmic membrane. This research empha-
sizes the strength of high-throughput gel-based proteome
analysis for getting new insights in posttranslational pro-
tein regulation. At this stage we do not know whether
membrane translocation and posttranslational modifica-
tion are coupled and how these processes are related to AI-
2 signaling. Nevertheless, these insights feed challenging
research on LuxS-based quorum sensing in S. Typhimu-
rium and possibly even other bacterial species.BMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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Methods
Bacterial strains and growth conditions
All strains and plasmids that were used in this study are
listed in Table 2. Salmonella Typhimurium SL1344 is the
wildtype strain [44]. For the 2D-DIGE analysis, Salmonella
strains were grown under in vivo mimicking conditions.
Growth monitoring during 48 h revealed that all strains
grow very much alike under the conditions tested. The
luxS mutant is unable to produce AI-2 due to the lack of a
crucial enzyme in the AI-2 synthesis pathway. An over-
night preculture in 5 ml Luria-Bertani broth (LB) medium
supplemented with 0.5% glucose was diluted 1:100 in
100 ml LB medium with 0.5% glucose, flushed with a gas
mixture of 97% N2 and 3% O2 during 15 minutes prior to
inoculation and sealed air-tight with a rubber cap to
mimic the low oxygen concentration known to induce
expression of Salmonella invasion proteins [45]. The cul-
tures were incubated non-shaking at 37°C for 5 h. In all
validation experiments, Salmonella  strains were grown
with aeration at 37°C in Luria-Bertani broth (LB) medium
[46]. Antibiotics were applied at the following concentra-
tions: 25 μg/ml chloramphenicol (for plasmids based on
pAYC184) and 100 μg/ml ampicillin (for plasmids based
on pFAJ1708). For the determination of the MIC of amp-
icillin, variable concentrations of ampicillin were used
(serial diluted twofold from 100 μg ml-1 to 3.125 μg ml-1)
[47]. Synthetic DPD (Omm Scientific Inc.) and BCIP
(Sigma) were used in concentrations of 70 μM and 50 μg
ml-1, respectively. Standard protocols were used for
molecular cloning [46]. All primers used are listed in
Table 3. All strains and constructs were finally verified by
PCR and sequencing analysis. The S. Typhimurium
SL1344 phoN  mutant (CMPG5726), the luxSβla  fusion
mutant (CMPG5729), and the FLAG-tagged LuxS strain
(CMPG5649) were all constructed with the procedure
described by Datsenko and Wanner [48] starting from the
plasmids pKD4 [48], pTn5-blam [49] and pSUB11 [50],
respectively. The luxS mutant was constructed by cloning
the luxS gene and flanking regions from SL1344 into the
SacI restriction site of plasmid pUCBM20 (Boehringer-
Mannheim) using primers PRO-196 and PRO-197, result-
ing in plasmid pCMPG5700. A kanamycin resistance cas-
sette was amplified from pUC18-2 [51] using primers
PRO-194 and PRO-195, containing ClaI restriction sites.
Subsequently, this cassette was inserted into the ClaI
restriction site of the luxS gene. The mutated luxS gene was
then cloned into the SacI restriction site of suicide plasmid
pCVD442 [52]. A chromosomal luxS mutant of SL1344
was obtained by double homologous recombination.
Construction of LuxS point mutation vectors
Point mutations were introduced into the coding
sequence of luxS, in order to change the different tyrosine
(Y) residues in phenylalanine (F) or aspartate (D). To this
end, the QuickChange site-directed mutagenesis kit (Strat-
agene, USA) was used. Shortly, point mutations were
introduced by PCR in plasmid pCMPG5700, carrying the
luxS gene and flanking regions, using the different primers
listed in Table 3. After restriction digesting the mother
strand DNA with DpnI, competent E. coli DH5α cells were
Table 2: Bacterial strains and plasmids
Name Description Reference
S. Typhimurium SL1344 Parent strain [44]
CMPG5649 S. Typhimurium luxS3xFLAG This work
CMPG5702 Insertion of a kanamycin resistance gene in the ClaI restriction site of the luxS gene of SL1344;luxS::KmR This work
CMPG5726 S. Typhimurium SL1344 ΔphoN This work
CMPG5729 S. Typhimurium SL1344 luxSβla This work
pTn5-blam Plasmid used as template for construction of CMPG5729 [49]
pKD4 Plasmid used as template for construction of CMPG5726 [48]
pSUB11 Plasmid used as template for construction of CMPG5649 [50]
pCVD442 Positive selection suicide vector [52]
pACYC184 Derivative of p15A; TcR; CmR [54]
pFAJ1708 Derivative of RK-2; ApR; TcR; contains nptII promoter of pUC18-2 [55]
pCMPG5664 pACYC184 containing the luxS gene of SL1344 [13]
pCMPG5700 pUCBM20 containing the luxS gene and flanking regions of SL1344 in SacI restriction site; ApR, lacZ This work
pCMPG5718 pACYC184 with luxS: Y88→F88 This work
pCMPG5719 pACYC184 with luxS: Y88→D88 This work
pCMPG5720 pACYC184 with luxS: Y126→F126 This work
pCMPG5721 pACYC184 with luxS: Y126→D126 This work
pCMPG5722 pACYC184 with luxS: Y131→D131 This work
pCMPG5723 pACYC184 with luxS: Y131→F131 This work
pCMPG5730 pACYC184 vector containing luxSphoA fusion protein with luxS promoter This work
pCMPG5734 pFAJ1708 containing PhoA with signal peptide; positive control This work
pCMPG5748 pFAJ1708 containing PhoA without signal peptide; negative control This work
pCMPG5743 pCMPG5664 with point mutation in luxS: C83→A83 This workBMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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transformed with the mutated plasmid DNA. Transform-
ants were selected on LB containing 100 μg/ml ampicillin,
50 μg/ml IPTG and 40 μg/ml X-gal. Constructs were veri-
fied by sequencing. Subsequently, the mutated luxS genes
(BamHI-Eco47III fragments) were cloned into the BamHI
and EcoRV restriction sites of vector pACYC184, which is
stable in Salmonella. The resulting plasmids were electro-
porated into CMPG5702.
pCMPG5743 containing a C83A point mutation in luxS
was constructed based on pCMPG5664 - expressing luxS
from its own promoter - according to the Quick site-
directed mutagenesis protocol (Stratagene, USA) and
sequenced to confirm the point mutation.
Construction of PhoA constructs
For the construction of the luxSphoA  fusion construct
(pCMPG5730), S. Typhimurium SL1344 luxS was ampli-
fied by PCR using PRO-208 and PRO-0415. The luxS frag-
ment was cloned into a pCRIITOPO vector (Invitrogen)
and subsequently subcloned in the HindIII site of the
PhoA fusion vector pPHO7 [53], kindly provided by Prof.
C. Gutierrez. Finally, the LuxS-PhoA fusion protein under
control of the luxS promoter was subcloned as a blunt
ended Ecl136II fragment into the EcoRV site of a Salmo-
nella compatible pACYC184 vector [54]. Positive and neg-
ative PhoA control constructs (pCMPG5734 and
pCMPG5748) were made by cloning the PhoA coding
sequence with or without signal peptide, amplified by
PCR with PRO-0719/PRO-1273 and PRO-0721, into the
XbaI and PstI cloning site of pFAJ1708, an RK-2 derived
low-copy-number expression vector containing the nptII
Table 3: Primers used in this study
Primer Sequencea Purposeb
PRO-194 AAATCGATAGGTCGACGGGCCCGGTACC FW CMPG5702
PRO-195 AAATCGATCGCTGCCGCAAGCACTCAGG RV CMPG5702
PRO-196 AAGAGCTCCATGTACTACCTGCCGTATGCG FW pCMPG5700
PRO-197 AAGAGCTCACGTATCCTGATTCAGCGGG RV pCMPG5700
PRO-510 GCCGCACCGGCTTTTTCATGAGCCTGATTGG FW Y88→F88
PRO-511 CCAATCAGGCTCATGAAAAAGCCGGTGCGGC RV Y88→F88
PRO-512 GCCGCACCGGCTTTGACATGAGCCTGATTGG FW Y88→D88
PRO-513 CCAATCAGGCTCATGTCAAAGCCGGTGCGGC RV Y88→D88
PRO-514 GGAGCTGAACGTTTTCCAGTGCGGTACG FW Y126→F126
PRO-515 CGTACCGCACTGGAAAACGTTCAGCTCC RV Y126→F126
PRO-516 GGAGCTGAACGTTGACCAGTGCGGTACG FW Y126→D126
PRO-517 CGTACCGCACTGGTCAACGTTCAGCTCC RV Y126→D126
PRO-518 CCAGTGCGGTACGTTTCAGATGCACTCGC FW Y131→F131
PRO-519 GCGAGTGCATCTGAAACGTACCGGACTGG RV Y131→F131
PRO-520 CCAGTGCGGTACGGATCAGATGCACTCGC FW Y131→D131
PRO-521 GCGAGTGCATCTGATCCGTACCGGACTGG RV Y131→D131
PRO-0177 TTGCACTTCCTTTCATTTGCTGTGGCCAGTTTGCGGGAAG
ACTTTCACCTGTGTAGGCTGGAGCTGCTTC
FW CMPG5726
PRO-0178 CATTATAGGATTACATCTGTTTATTATTGCCTGATCCGGAG
TGAGTCTTTCATATGAATATCCTCCTTA
RV CMPG5726
PRO-1428 AGCTGGCGCTGCCGAAAGAAAAACTGCAGGAACTGCATA
TTCTGTCTCTTATACACATCTCA
FW CMPG5729
PRO-1429 TAAACCGGGGTTAATTTAAATACTGGAACCGCTTACAAAT
AAGAGTCTCTTATACACATCTGGT
RV CMPG5729
PRO-0889 CTCGCCGATGGGCGCCCGCACCGGCTTTTAC FW C83→A83
PRO-0890 GTAAAAGCCGGTGCGGGCGCCCATCGGCGAG RV C83→A83
PRO-208 ATGAATTCGCGGCACCGGGAAAGCGTTCGG FW luxSphoA fusion
PRO-0415 GTTTCCAAGCTTATATGCAGTTCCTGCA RV luxSphoA fusion
PRO-0719 GAAGGGTCTAGATGAAACAAAGCACTA FW PhoA with signal peptide
PRO-1273 ATTCTAGACATGGAGAAAATAAAATGCCTGTTCTGGAAAA
CCG
FW PhoA without signal peptide, contains ribosome binding site
PRO-0721 ATCTGCAGTTATTTCAGCCCCAGAG RV PhoA control plasmids
PRO-0238 GCTGGCGCTGCCGAAAGAAAAACTGCAGGAACTGCATAT
TGACTACAAAGACCATGACGG
FW CMPG5649
PRO-0239 CCGGGGTTAATTTAAATACTGGAACCGCTTACAAATAAGA
CCATATGAATATCCTCCTTAG
RV CMPG5649
a Point mutations are indicated in bold
b FW: Forward primer; RV: Reverse primerBMC Microbiology 2009, 9:198 http://www.biomedcentral.com/1471-2180/9/198
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promoter of pUC18-2 [55]. All constructs were verified by
PCR and sequencing and finally electroporated to the
CMPG5726 background. For protein fractionation analy-
sis of FLAG-tagged LuxS, the negative PhoA control con-
struct pCMPG5748 was electroporated to the CMPG5649
background and used as cytoplasmic control protein.
Determination of β-lactamase minimal inhibitory 
concentrations
The minimal inhibitory concentrations (MIC) were deter-
mined as previously described [47].
PhoA activity assay
Alkaline phosphatase assays were performed according to
the procedure of Daniels et al. [56].
2D gel electrophoresis
Total protein sampling and 2D-DIGE analysis were essen-
tially performed as previously described [57]. Four biolog-
ical replicates were taken for each strain of which two were
labeled with Cy3 and two were labeled with Cy5. The
internal standard sample was labeled with Cy2 and
included on each gel, while the other protein samples
were randomized across all gels. The first dimension was
performed on 24 cm Immobiline DryStrips with a 3-7
non-linear pH range (GE Healthcare). Analysis of the gel
images was performed using DeCyder™ 6.5 software (GE
Healthcare). A t-test analysis was used to identify spots
that were differentially expressed between the two strains.
Spots with a p-value < 0.01 and a more than 1.5 fold
change in expression level were considered differentially
expressed. For identification, spots of interest were manu-
ally matched to the protein pattern in the preparative gel
images and included in a pick list. Spot picking was exe-
cuted automatically with the Ettan SpotPicker (GE Health-
care). For 2DE analysis of LuxS point mutant strains,
protein samples were taken at OD595 1 and 30 μg protein
was loaded per strip. Gels were stained with Sypro Ruby
(Invitrogen).
Cell fractionation and Western blotting
Cells were grown in LB medium to mid-exponential phase
(OD595 1). Total protein samples were taken as described
by Sittka et al. [58]. For SDS-PAGE, 0.01 OD was loaded.
Cell fractionation was performed according to a proce-
dure from Randall et al. [59]. Periplasmic, cytoplasmic
and membrane protein fractions were quantitated with
the RC DC protein assay from Bio-rad and 10 μg was
loaded per lane.
The antibodies used included mouse monoclonal anti-
PhoA (Sigma, 1:10 000) for detection of the LuxS-PhoA
fusion protein; mouse polyclonal anti-PhoA (Chemicon
Int., 1:5000) for detection of PhoA expressed by the con-
trol plasmids; rabbit anti-MBP (New England Biolabs,
1:5000); rabbit anti-OmpA [60]; goat anti-mouse alkaline
phosphatase IgG (Sigma, 1:10 000) and goat anti-rabbit
alkaline phosphatase IgG (Sigma, 1:10 000).
Abbreviations
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